Praxis Precision Medicines (PRAX) Invested Capital (2022 - 2025)
Historic Invested Capital for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $343.5 million.
- Praxis Precision Medicines' Invested Capital fell 1023.37% to $343.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $343.5 million, marking a year-over-year decrease of 1023.37%. This contributed to the annual value of $445.4 million for FY2024, which is 53938.05% up from last year.
- As of Q3 2025, Praxis Precision Medicines' Invested Capital stood at $343.5 million, which was down 1023.37% from $404.2 million recorded in Q2 2025.
- Praxis Precision Medicines' 5-year Invested Capital high stood at $445.4 million for Q4 2024, and its period low was $64.5 million during Q1 2023.
- In the last 4 years, Praxis Precision Medicines' Invested Capital had a median value of $191.0 million in 2022 and averaged $233.4 million.
- Its Invested Capital has fluctuated over the past 5 years, first tumbled by 6625.1% in 2023, then surged by 53938.05% in 2024.
- Praxis Precision Medicines' Invested Capital (Quarter) stood at $76.1 million in 2022, then fell by 8.46% to $69.7 million in 2023, then soared by 539.38% to $445.4 million in 2024, then fell by 22.89% to $343.5 million in 2025.
- Its Invested Capital stands at $343.5 million for Q3 2025, versus $404.2 million for Q2 2025 and $439.2 million for Q1 2025.